Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Short-term Investments (2022 - 2025)

Historic Short-term Investments for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Q3 2025 value amounting to $25.6 million.

  • Harmony Biosciences Holdings' Short-term Investments rose 1070.15% to $25.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.6 million, marking a year-over-year increase of 1070.15%. This contributed to the annual value of $14.2 million for FY2024, which is 6606.46% down from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Short-term Investments of $25.6 million as of Q3 2025, which was up 1070.15% from $19.2 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Short-term Investments ranged from a high of $79.3 million in Q4 2022 and a low of $14.2 million during Q4 2024
  • Over the past 4 years, Harmony Biosciences Holdings' median Short-term Investments value was $34.5 million (recorded in 2024), while the average stood at $36.4 million.
  • In the last 5 years, Harmony Biosciences Holdings' Short-term Investments skyrocketed by 20370.79% in 2023 and then plummeted by 6606.46% in 2024.
  • Quarter analysis of 4 years shows Harmony Biosciences Holdings' Short-term Investments stood at $79.3 million in 2022, then crashed by 47.31% to $41.8 million in 2023, then plummeted by 66.06% to $14.2 million in 2024, then skyrocketed by 80.35% to $25.6 million in 2025.
  • Its Short-term Investments was $25.6 million in Q3 2025, compared to $19.2 million in Q2 2025 and $18.0 million in Q1 2025.